This was the stock's fifth consecutive day of losses.

On January 16, Kenvue Inc. (NYSE:KVUE) declared a quarterly dividend of $0.205 per share, having raised it by 2.5% in July 2024. The company has been growing its payments for 62 consecutive years.

Kenvue faces demand weakness, retailer destocking, and price cuts, raising concerns about structural issues and recovery.

Shares of Kenvue led S&P 500 decliners Tuesday after the consumer health giant's chief executive indicated the firm faces ...

Kenvue, a spinoff from Johnson & Johnson, offers well-known consumer health brands and stable dividends. Investing in Kenvue is straightforward: Open a brokerage, search for KVUE stock, set an ...

Kenvue Inc. (NYSE:KVUE) is among the Best Beauty Stocks and the world’s largest pure-play consumer health company by revenue, with $15 billion in annual revenue.

Investors in Kenvue Inc (Symbol: KVUE) saw new options begin trading today, for the December 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

New Jersey-based Kenvue Inc. is a consumer health company operating across the Americas, Europe, EMEA, and the Indo-Pacific.

Kenvue Debuts on Fortune 500 List. SUMMIT, N.J., June 02, 2025--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has ...

Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on ...

Johnson & Johnson (NYSE:JNJ) is one of the Best Wide Moat Dividend Stocks to Invest in. Johnson & Johnson (NYSE:JNJ) is a long-established leader in the healthcare industry, with a strong portfolio of ...